SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

Vivos Therapeutics Reports Third Quarter 2026 Financial Results and Provides Operational Update

Revenue rises 24% quarter over quarter as Third quarter operating loss improves 18% year over year o

VVOS

Related stories